SCR-LIP-000747 · Claim · machine-readable JSON →
DXA regional fat measures are used in lipedema studies as descriptive variables or as proxy definitions of a lipedema-like phenotype.
General proposition consolidated from 3 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 4 source(s) · by Amato
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (4)
- JCEM Case Reports, 2026, 4, luag018 (2026) ✓ verified — consistent · case report · 2026 · reading confidence: moderate
“Total body, trunk, leg and arm fat masses, the android-to-gynoid fat ratio (in general, the android region is the area between the lower ribs and the pelvis and the gynoid region is the area below the pelvis to the upper thighs) and fat-free mass were assessed by using dual-energy X-ray absorptiomet”
Case report: DXA assessed total, trunk, leg and arm fat masses and android-to-gynoid ratio in a lipedema patient, alongside MRI regional volumes.
The abstract describes DXA being applied to a lipedema patient to measure regional fat distribution, but as a single case report it does not test or validate DXA's ability to identify a characteristic lipedema fat distribution pattern; it i - Unveiling kinesiophobia: A hidden challenge (2026) ✓ verified — consistent · case control · 2026 · reading confidence: high
“the lipedema patients were evaluated in terms of extremity volumes, and total and mean lower extremity fat mass by dualenergy X-ray absorptiometry”
In 40 lipedema patients, DXA lower-extremity fat mass did not differ between high and low kinesiophobia groups.
DXA is used to measure lower extremity fat mass in lipedema patients, but the abstract does not test whether DXA identifies a lipedema-specific fat distribution pattern; it only uses DXA as a measurement tool within a kinesiophobia study, m - The Lipedema Phenotype is Inversely Associated with Celiac Disease Autoimmunity: Testing the Immunological Shield Hypothesis in NHANES — Amato et al. (2025) ✓ verified — consistent · cross sectional · n=3833 · 2025 · risk of bias: moderate · reading confidence: high
“HOMA-IR mediano 44,2% menor no fenótipo lipedema (1,35 [IQR 0,95–2,01] vs 2,42 [IQR 1,47–4,30]; p<0,001)”
In NHANES women, a lipedema-like phenotype defined by DXA leg-to-trunk fat ratio >90th percentile had 44.2% lower HOMA-IR (p<0.001); exploratory, unvalidated proxy.
exploratory; DXA proxy may capture gynoid obesity - Exploring the Immunological Shield Hypothesis: A Population-Based Exploration of Phenotypic Divergence Between Lipedema and Celiac Disease Autoimmunity — Amato et al. (2026) ✓ verified — consistent · cross sectional · 2026 · reading confidence: high
The same DXA-defined lipedema-like phenotype was associated with lower diabetes prevalence (1.8% vs 8.1%; OR 0.21) in an exploratory population analysis.
Exploratory cross-sectional population study directly examines whether a peripheral/gynoid (lipedema-like) fat distribution confers metabolic protection, reporting lower HOMA-IR and reduced diabetes prevalence with dose-response; supports t
Context (PECO)
Answers these questions
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000031